In the quiet, mist-covered ridges of East Tennessee, armed guards and miles of razor wire protect one of the government's top research facilities.

For more than 80 years, the Oak Ridge National Laboratory has been where the U.S. goes when the stakes are existential.

This is where the Manhattan Project learned how to split the atom.

It's where uranium enrichment moved from theory to industrial reality.

Today, the facility is humming with a "Manhattan Project" of today's age... a complete reset of America's AI industry.

At the heart of this effort sits Oak Ridge's crown jewel, Frontier, the world's most powerful supercomputer.

Frontier can perform more than a quintillion calculations per second – a number so large it borders on meaningless.

To put some context to it... if every human on Earth performed one calculation per second, nonstop, it would take more than four years to match what Frontier does in a single second.

The computer's storage system can hold 33 times the amount of data that's in the entire Library of Congress.

Frontier is a beast of a machine. But what's coming next out of Oak Ridge will dwarf it...

We're calling it the Genesis device.

The plan, set in motion by Executive Order No. 14363, isn't just to build a bigger supercomputer. It's to connect them all.

The U.S. Department of Energy ("DOE") has more than 400 supercomputers at 17 national laboratories across the country. To create the Genesis device, a specialized, ultra-high-speed fiber network will link all of them to Frontier.

From elite laboratories like Lawrence Livermore in California to Argonne in Illinois – Genesis will create a single, unified platform.

It's difficult to think about the potential power of Genesis. But imagine 17 of the smartest people on Earth suddenly being able to share thoughts instantaneously, working in unison.

To be clear, Genesis isn't just trying to create a supercool version of ChatGPT. It's a machine designed to automate discovery itself.

Consider the field of medicine... Traditionally, developing a new drug takes more than a decade and costs billions of dollars. Most drug companies fail. And 90% of drugs don't make it out of clinical trials.

The Genesis device will be able to simulate the interaction of billions of molecules in days. This has the potential to cure diseases that have plagued us for generations.

Along with biotechnology, Genesis will try to innovate several other industries... including nuclear fission and fusion, critical materials, quantum science, advanced manufacturing, and semiconductors.

The stated goals for Genesis are ambitious, to say the least... Take 10 years of AI progress and force it to happen in 10 months, or less.

Now, I've always been something of an AI skeptic.

The Genesis project has the possibility of beating China to artificial general intelligence, or AGI – a superintelligent AI that can function on its own...

It has the possibility of vastly improving our country's industries...

Will America's scientists ever pull that off? We don't know.

But here's what we do know... The White House is not wasting time. Executive Order No. 14363 set a very aggressive timeline, with specific deadlines that started last November. There's a 270-day deadline for initial operating capability.

Plus, the smartest people in the world are involved. These include OpenAI CEO Sam Altman and Nvidia (NVDA) CEO Jensen Huang. Combined with other tech giants and the brightest at the DOE, this is a rare moment when the federal government and private industry are pulling in the same direction.

This project is moving fast. And money is flowing.

The DOE made a $320 million initial investment for Genesis...

Companies involved in AI chips, models, and quantum computing – all the stuff of science fiction – stand to make a lot of money throughout the life of this project. This will be the most sophisticated AI network ever created.

But the biggest hurdle this project faces is something much more basic...

Genesis is creating a level of sustained, always-on computational demand. These machines won't sleep. And they can't afford outages.

A project of this magnitude requires a staggering amount of power. And, in general, generating enough power is the biggest hurdle to reaching an AI future.

Global AI power demand is projected to create severe energy constraints by 2027 or 2028. There simply might not be enough power to supply all of the world's new AI projects...

And that could put serious pressure on both the power grid and many of today's biggest tech stocks.

Last week, two of my colleagues – Marc Chaikin and Jeff Brown – went on camera to talk about this looming energy crisis...

They explained that it could trigger a transition from the first phase of the AI revolution to the second. It all has to do with a new innovation from an AI company that's going public soon.

Marc and Jeff say this is the single biggest opportunity for wealth creation that they've seen in their combined 90 years of investing.

Investors who know what's going on and position themselves strategically could see up to 12 times gains... Meanwhile, those who don't prepare could be stuck with massive losses.

Today is your last chance to hear about this hidden threat in AI and learn how you can take advantage. Click here for all the details.

What We're Reading...

Here's to our health, wealth, and a great retirement,

Dr. David Eifrig and the Health & Wealth Bulletin Research Team
May 6, 2026

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top